Genne’ DeHenau McDonald, PT SIBONE, Inc.

Topics include:
Test Sequence
Lumbar Evaluation
SI Joint: Physical Exam
SI Joint: Provocative Tests
Assess Hip: Physical Examination


The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.
 
There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.sibone.com/risks

One or more of the individuals named herein may be past or present SIBONE employees, consultants, investors, clinical trial investigators, or grant recipients. Research described herein may have been supported in whole or in part by SIBONE.

U.S. Patent Nos. 8,202,305; 8,840,623; 8,986,348; and 9,039,743; pending U.S. and foreign patent applications.

SIBONE and iFuse Implant System are registered trademarks of SIBONE Inc. © 2015 SIBONE, Inc. All rights reserved.

9380.120615